Comparison Between Dexamethasone and Ibuprofen on Pain Prevention and Control Following Surgical Implant Placement

NCT ID: NCT02763059

Last Updated: 2025-11-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

132 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background and aim: Postoperative pain is an adverse effect of oral surgeries and may therefore be prevented or minimized. This study compares the efficacy of preemptive ibuprofen and dexamethasone protocols in pain prevention and control after surgical implant placement.

Methods: For this prospective, double-masked, parallel-group, placebo-controlled, randomized clinical trial, 117 dental implants were placed. The groups received three different protocols 1 hour before surgery:

1. 600 mg ibuprofen (and another 600 mg dose 6 hours after the first dose);
2. 4 mg dexamethasone (and another 4 mg 6 hours after the first dose) or
3. placebo.

Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary. Pain intensity was evaluated by a 101-point numeric rate scale and visual analogue scale, additionally discomfort was evaluated using a four-point verbal rate scale, hourly for the first 8 hours after surgery and three times a day on the following 3 days.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective clinical trial investigated the efficacy of preemptive medication in mitigating postoperative pain following dental implant surgeries. With a sample size of 117 participants, the study employed a double-masked, parallel-group, placebo-controlled design. Patients were randomly assigned to receive one of three treatment protocols-an ibuprofen regimen, a dexamethasone regimen, or a placebo-administered one hour before surgery. Pain intensity and discomfort were assessed using numeric, visual, and verbal scales hourly for the first 8 hours post-surgery, followed by thrice-daily evaluations for the next 3 days. Additionally, rescue medication (acetaminophen) was provided to manage pain as needed. The study aimed to determine whether ibuprofen or dexamethasone could effectively alleviate postoperative pain compared to a placebo to highlight optimal pain management strategies for dental implant procedures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Measurement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1- Received Ibuprofen (N=44)

This group receives 1 hour before surgery 600 mg ibuprofen (and another 600 mg dose 6 hours after the first dose).

Acetaminophen 1000 mg: A Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary.

Group Type ACTIVE_COMPARATOR

Ibuprofen 600 mg

Intervention Type DRUG

This group receives 1 hour before surgery 600 mg ibuprofen (and another 600 mg dose 6 hours after the first dose);

Acetaminophen 1000 mg

Intervention Type DRUG

A Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary.

Group 2- Received Dexamethasone (N=44)

This group receives 1 hour before surgery 4 mg dexamethasone (and another 4 mg 6 hours after the first dose) Acetaminophen 1000 mg: A Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary.

Group Type ACTIVE_COMPARATOR

Dexamethasone 4 mg

Intervention Type DRUG

This group receives 1 hour before surgery 4 mg dexamethasone (and another 4 mg 6 hours after the first dose)

Acetaminophen 1000 mg

Intervention Type DRUG

A Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary.

Group 3 - Received Placebo (N=44)

This group receives 1 hour before surgery placebo. Acetaminophen 1000 mg: A Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

This group receives 1 hour before surgery placebo.

Acetaminophen 1000 mg

Intervention Type DRUG

A Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ibuprofen 600 mg

This group receives 1 hour before surgery 600 mg ibuprofen (and another 600 mg dose 6 hours after the first dose);

Intervention Type DRUG

Dexamethasone 4 mg

This group receives 1 hour before surgery 4 mg dexamethasone (and another 4 mg 6 hours after the first dose)

Intervention Type DRUG

Placebo

This group receives 1 hour before surgery placebo.

Intervention Type DRUG

Acetaminophen 1000 mg

A Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

600 mg ibuprofen (and another 600 mg dose 6 hours after the first dose). 4 mg dexamethasone (and another 4 mg 6 hours after the first dose) Acetaminophen 1000 mg A Rescue medication (1000 mg acetaminophen) was given to each patient who was instructed to take it if necessary.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent for the described procedure
* Surgical placement of a single endosteal implant
* Age of at least 18 years

Exclusion Criteria

* The need for bone grafting or sinus lift for implant placement
* Pregnant and lactating women
* Metabolic disorders
* Immunocompromised status
* Hemophilia or bleeding disorders
* Drug or alcohol abuse
* Treatment with steroids in the previous 6 months
* History of radiation therapy in the head and neck
* Psychiatric disorders
* Inability to understand the procedure described in the questionnaire
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Abdulaziz University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maha A. Bahammam

Associate Professor and Consultant of Periodontology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maha Bahammam, Sc, CAGS, EdM, DABP

Role: STUDY_DIRECTOR

King Abdulaziz University

References

Explore related publications, articles, or registry entries linked to this study.

Bahammam MA, Kayal RA, Alasmari DS, Attia MS, Bahammam LA, Hassan MH, Alzoman HA, Almas K, Steffens JP. Comparison Between Dexamethasone and Ibuprofen for Postoperative Pain Prevention and Control After Surgical Implant Placement: A Double-Masked, Parallel-Group, Placebo-Controlled Randomized Clinical Trial. J Periodontol. 2017 Jan;88(1):69-77. doi: 10.1902/jop.2016.160353. Epub 2016 Aug 26.

Reference Type DERIVED
PMID: 27562219 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1434/254/287

Identifier Type: -

Identifier Source: org_study_id